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Background/aim: Chronic spontaneous urticaria (CSU) is a chronic disease with an unknown etiology. In human leukocyte antigen
(HLA) system, the association of class I and class II antigens with autoimmune diseases has been identified and HLA antigens that have
a tendency to or can prevent chronic urticaria have been studied. The aim of this study is to investigate the association between chronic
spontaneous urticaria and HLA class I and class II antigens.
Materials and methods: A total of 80 subjects, 40 patients with CSU and 40 healthy individuals were enrolled in the study. DNA sample
isolation from blood was primarily done by the real-time polymerase chain reaction (RT-PCR) technique for the first time. Using HLA
SSP Typing Kit (ROSE Cat. No: 800118) PCR technique, HLA-A, B, C, DRB and DQB alleles from DNA samples were analyzed.
Results: The mean age was 36.80 ± 9.48 years and the duration of the disease was 4.26 ± 5.18 years. Among the HLA class I and class
II antigens, HLA-A was detected significantly more often in the control group (P = 0.039). HLA-DRB1 was more often detected in the
CSU group but no statistical difference (P > 0.05).
Conclusion: It can be considered that HLA-DRB1 may have a tendency to CSU, while HLA-A might prevent the disease.
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1. Introduction
Urticaria is a cutaneous vascular reaction characterized
by formation erythematous, edematous, itchy papules and
plaques with varying sizes involving the upper and middle
dermis, with mast cells playing a role in its pathogenesis. If
this vascular reaction involves deep dermis, subcutaneous
tissues, or mucosae, it is called angioedema. While
urticarial lesions disappear within 24 h, disappearance
of angioedema can take up to 72 h. Lesions are defined
as acute urticaria lasting less than 6 weeks and as chronic
urticaria (CU) lasting 6 weeks or longer. There are 2
subtypes of chronic urticaria; chronic spontaneous
urticaria (CSU) and inducible urticaria. Whereas an
etiologic cause can be detected frequently in patients
with acute urticaria, any triggers have not been found
in approximately 80% of patients with chronic urticaria
[1,2]. Although many studies have been conducted on
the etiology and pathogenesis of CSU, its reason and
mechanism still remain unknown.
In recent years, studies on the etiology of chronic
urticaria have noted autoimmunity in approximately 1/3
of cases [3–6]. The association of both class I and class II

antigens with autoimmune diseases has been described in
the human leukocyte antigen (HLA) system, also known
as major histocompatibility complex (MHC) [7,8]. There
are some studies investigating the association between
chronic spontaneous urticaria and HLA antigens. In these
studies, it has been shown that some alleles are susceptible
to disease and some alleles may be protective [9–16].
The objective of this study is to examine the relation
between chronic spontaneous urticaria and HLA class I
and class II antigens.
2. Material and methods
2.1. Patients and study design
The cross-sectional study was included a total of 80 subjects;
40 patients aged 18 years and above who were diagnosed
as CSU patients between August 2017 and December
2017 in the Immunology–Allergy Clinic, and 40 healthy
individuals as a control group with no history of urticaria.
All participants were informed of the nature of the
study and written consent was obtained from each.
For this research, approval was received from the
Ethics Committee for Noninvasive Clinical Studies at the
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(No: E.44836). The study was conducted in accordance
with the principles of the Declaration of Helsinki.
A detailed history and physical examination were
obtained from each patient, with use of medications,
diet, triggering physical factors, history of autoimmune
disease, neoplastic disease, and infectious conditions.
In the laboratory, complete blood count, erythrocyte
sedimentation rate, C-reactive protein, liver function
tests, renal function tests, antinuclear antibody, serological
tests for hepatitis B and C, stool parasite screening, urine
analysis, complement 3 (C3), complement 4 (C4), thyroid
stimulating hormone (TSH), antithyroglobulin (anti-TG),
antithyroid peroxidase antibody (anti-TPO), and total IgE
were measured. Patients who had a history of autoimmune
disease (such as connective tissue disease, vasculitis,
and thyroiditis), malignancy, infectious conditions, and
triggering factor (such as diet, medication, and triggering
physical factors) or detected during the evaluation of the
patients were excluded from the study.
2.2. DNA isolation and determination of HLA antigens
HLA antigens were performed on blood samples and DNA
samples isolation from blood was primary done by realtime polymerase chain reaction (RT-PCR) technique for
the first time.
Isolation of DNA samples from blood was conducted
with the commercial kit (General DNA Extraction Kit,
Cat. No: was ab156893, Abcam). DNA concentrations in
the isolated 80 blood samples were measured via Qubit
fluorometers. Using HLA SSP Typing Kit (ROSE Cat. No:
800118) PCR technique, HLA-A, B, C, DRB, and DQB
alleles were detected from DNA samples. The primers,
which designed specific alleles and using with specific
DNA polymerases, and the alleles, which involved with
HLA subtype, were determined.
2.3. Statistical analyses
Power analysis was performed with 5% alpha level and
80% test power for sample size. Statistical analyses were
carried out using the IBM SPSS 18.0 statistics program.
The categorical ones of the descriptive data were expressed
using numbers and percentages. The frequency of antigens
(HLA-A, HLA-DQB and HLA-DRB1) from patients and
controls were compared chi-square analysis with Fisher
exact test. A P value of <0.05 was considered statistically
significant.
3. Results
A total of 40 CSU patients, 12 male and 28 female, were
enrolled in this study. The mean age was 36.80 ± 9.48 years
and the duration of the disease was 4.26 ± 5.18 years. The
mean age of disease onset was 32.2 ± 10.2 years. Comorbid
diseases were 5% diabetes mellitus, 10% hypertension.
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When HLA class 1 and class 2 antigens were compared,
HLA-A was detected in 6 (15%) patients in the CSU group
and 14 (35%) in the control group (P = 0.039). HLADRB1 was detected in 13 (32.5%) patients in the CSU
group and 7 (17.5%) in the control group but there was
no significant difference (P > 0.05). The frequency of HLA
class 1 and 2 antigens is shown in Table 1. HLA-A*03 of
the HLA-A alleles was detected to be higher in the control
group (Table 2). HLA-DQB was detected in the same ratio
in both groups, and suballels were detected similar ratio
(Table 3). When the phenotypes of HLA-DRB1 alleles
were compared, HLA-DRB1*01 was detected in a higher
ratio in CSU group (Table 4).
4. Discussion
Chronic spontaneous urticaria is a disease of unknown
etiology, usually occurring in adulthood, which is twice as
common in females [4–6]. The disease usually begins in
the third to fifth decades of life and the duration of the
disease varies from 2 to 5 years [17–21]. In our study, in
accordance with the literature; 70% of the CSU patients
were female, the mean age of onset of disease was 32.2
± 10.2 years, and the duration of disease was 4.26 ± 5.18
years.
Currently, etiopathogenesis of chronic urticaria cannot
be clearly understood and approximately 80% of patients
have no etiological cause [1,2]. In studies on the etiology,
autoimmunity is deemed responsible for approximately
1/3 of patients [1–6]. Although the exact mechanism of
etiopathogenesis is not known, some studies support
the hypothesis that HLA alleles may play a role in the
pathogenesis of chronic urticaria during the initiation of

Table 1. Frequency of HLA class 1 and class 2 antigens in study
groups.
CSU
n = 40

Control
n = 40

HLA-A**

6 (15%)

14 (35%)

HLA-B

3 (7.5%)

3 (7.5%)

HLA-C

1 (2.5%)

1 (2.5%)

HLA-DQB

9 (22.5%)

9 (22.5%)

HLA-DRB1

13 (32.5%)

7 (17.5%)

HLA-DRB2

0

0

HLA-DRB3

2 (5%)

2 (5%)

HLA-DRB4

1 (2.5%)

2 (5%)

HLA-DRB5

2 (5%)

2 (5%)

CSU: Chronic spontaneous urticaria; HLA: Human leukocyte
antigen.
**P < 0.05
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Table 2. Phenotype frequency of HLA-A alleles.
CSU
n = 40

Control
n = 40

HLA-A**

6 (15%)

14 (35%)

A*01

2 (5%)

A*02

0

A*03

Table 4. Phenotype frequency of HLA-DRB1 alleles.
CSU
n = 40

Control
n = 40

HLA-DRB1

13 (32.5%)

7 (17.5%)

2 (5%)

DRB1 * 01

5 (12.5%)

2 (5%)

0

DRB1 * 04

0

0

1 (2.5%)

6 (15%)

DRB1 * 07

2 (5%)

1 (2.5%)

A*11

0

0

DRB1 * 0901

1 (2.5%)

1 (2.5%)

A*12

0

0

DRB1 * 10

0

0

A*24

1 (2.5%)

1 (2.5%)

DRB1 * 11

0

0

A*29

0

0

DRB1 * 12

1 (2.5%)

0

A*30

0

2 (2,5%)

DRB1 * 1302

2 (5%)

1 (2.5%)

A*33

1 (2.5%)

1 (2.5%)

DRB1 * 14

0

1 (2.5%)

A*74

0

0

DRB1* 15

0

0

CSU: Chronic spontaneous urticaria; HLA: Human leukocyte
antigen.
**P < 0.05

CSU: Chronic spontaneous urticaria; HLA: Human leukocyte
antigen.

Table 3. Phenotype frequency of HLA-DQB alleles.

similar ratios in the study groups, whereas HLA-A*03 was
higher in the control group.
HLA-B, one of the HLA class I antigens, was found
to be in higher ratios in patients with chronic urticaria.
Similar to Bozek et al.’s [14] study that was conducted
in Poland, Çoban et al. [13] also showed that HLA-B*44
allele was found to be in higher ratios in patients with
CU, in Turkey. Moreover, Calamita et al. [16] in Brazil
found that HLA-B*50 allele was higher in patients with
CSU. In another study conducted by Calamita et al. [23],
the prevalence of HLA-B*14 was found to be higher in
patients with CSU with positive anti-TPO antibodies.
Another study conducted in Turkey by Aydogan et al. [12]
showed that the HLA-Bw4 allele is significantly higher in
the chronic ordinary urticaria patient group. In our study,
since the frequency of HLA-B was detected in 3 patients
in each study group, the subgroup allele study was not
performed.
In studies investigating HLA class II antigens,
especially HLA-DRB1*04 allele was more often detected
in the patient group. In the studies conducted by Bozek
et al. [14] and Öztaş et al. [10] HLA-DRB1*04; and in
the study by O’Donnell et al. [9] both HLA-DRB1*04
and HLA-DQB1*0302 (DQ8) were more common in the
patient group. Chen et al. [11] found that HLA-DRB1*12
and HLA-DRB1*0901 alleles were higher in CU patients.
Çoban et al. [13] found that HLA-DRB1*01 and HLADRB1*15 alleles were predominant in CU group. Although
the HLA-DRB1*15 allele was detected as a predominant
allele in the chronic idiopathic urticaria (CIU) patient
group in this study, it was found significantly less in the

CSU
n = 40

Control
n = 40

HLA-DQB

9 (22.5%)

9 (22.5%)

DQB1 * 02

1 (2.5%)

2 (5%)

DQB1 * 0302

3 (7.5%)

2 (5%)

DQB1 * 05

1 (2.5%)

0

DQB1 * 0609

0

2 (5%)

CSU: Chronic spontaneous urticaria; HLA: Human leukocyte
antigen.

immune responses [10]. It has been shown that some HLA
alleles may be responsible for chronic urticaria and some
alleles may be protective [22]. However, there is still no
association demonstrated between specific HLA alleles
and identified chronic urticaria subtypes [13].
There are some studies showing that HLA-A is a
protective allele for chronic urticaria. Aydogan et al. [12]
showed in a study conducted in Turkey that HLA-A*24
allele was higher in the control group. In other study
that was done in Poland, Bozek et al. [14] reported that
HLA-A*33 allele was higher in the control group. Similar
to these 2 studies, it was found in our study that HLA-A
was significantly higher in the control group (P = 0.039).
However, in our study, HLA-A*24 and A* 33, which are
among the sub alleles of HLA-A, were found to be in
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Table 5. Frequency of HLA class I and class II Antigens in chronic urticaria.
Findingsincreased alleles

Findingsdecreased alleles

II

DRB1*04
DQB1*0302

DRB1*15
DQB1*06

42-CU

II

DRB1*04

No significant
difference

PCR-SSP

42-CU

II

DRB1*12
DRB1*0901

No significant
difference

Turkey

LCT

55-COU

I,II

BW4
DQ1

A24

Çoban et al., 2008

Turkey

PCR-SSP

40-CU

I,II

B44
DRB1*01
DRB1*15

No significant
difference

Bozek et al., 2010

Poland

LCTPCR-SSP

115-CSU

I,II

B44
DRB1*04

A33

Calamita et al., 2013

Brazil

PCR-SSOflow cytometry

42-CSU

I,II

No differences

No significant
difference

Author

Country

Method

n-Diagnosis

O’Donnell et al., 1999

U.K.

PCR-SSP

100-CIU

Oztas et al., 2004

Turkey

PCR-SSP

Chen et al., 2005

China

Aydogan et al., 2006

HLA
class

LCT: Lymphocytotoxicity assay; PCR‐SSP: Polymerase chain reaction sequence single specific primer; PCR-SSO: Polymerase chain
reaction sequence specific oligonucleotide; CIU: Chronic idiopathic urticaria; CU: Chronic urticaria; CSU: Chronic spontaneous
urticaria; COU: Chronic ordinary urticaria.

study of O’Donnell et al. [9]. In our study, as in many
studies, DRB1 allele was found to be higher in the CSU
group, whereas HLA-DRB1*01 was found to be in higher
ratio. HLA-DRB1*04 was not detected in the patient or
control groups.
An HLA class II antigen, HLA-DQ1 were found to
be significantly higher in the patient group in the study
performed by Aydogan et al.[12].
HLA-DQB1*06 (DQ6) allele was found to be
significantly less in the CIU group in the study of
O’Donnell et al. [9] and HLA-DQB1*05 allele was found to
be significantly less in the CU group in the study by Chen
et al. [11]. In our study, HLA-DQB was found to be in the
same number in both groups and suballeles were similar.
When
all
these
studies
were
evaluated
collectively, different results were found in different
ethnicities[7,9,10–16,22,23]. The obtained data were
shown in Table 5.
In the study of Çoban et al.[13], the last published study
from Turkey about HLA class I and class II genotyping in
patients with chronic urticaria, the autologous serum skin
test was performed but was not represent any difference
regarding HLA class I and II alleles. In this study, HLA-B44,
HLA-DRB1*01, HLA-DRB*15 frequency was significantly
higher in the patient group. There was no significant
difference in HLA-A allelic distribution between the
patient and control groups. However, it is not specified
whether chronic urticaria patients included in the study
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are chronic spontaneous urticaria or chronic inducible
urticaria. In addition, autoimmune diseases, malignancy,
infectious conditions accompanying chronic urticaria,
and triggering factor were not specified. In our study, only
chronic spontaneous urticaria patients were included;
patients with inducible urticaria were excluded. Patients
who had a history of autoimmune disease, malignancy,
infectious conditions, and triggering factors were excluded
from the study.
Similar to other studies, HLA-A was higher in the
control group, whereas HLA-DRB1 was higher in the CSU
group in our study. According to all these results, although
different results were found in terms of suballeles, HLADRB1 may have a tendency to CSU, while HLA-A might
prevent the disease.
Epidemiological studies involving a larger number of
patients may demonstrate the effect of the HLA-DRB1
allele and suballeles on the disease.
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